Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,423
Total Claims
$938K
Drug Cost
431
Beneficiaries
$2,177
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-91%
Opioid rate vs peers
0.2% vs 2.2% avg
+54%
Cost per patient vs peers
$2,177 vs $1,411 avg
Opioid Prescribing
0.2%
Opioid Rate
23
Opioid Claims
$552
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 0 claims · $0
Generic: 8,786 claims · $226K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 767 | $206K |
| Bictegrav/Emtricit/Tenofov Ala | 12 | $48K |
| Rifaximin | 30 | $45K |
| Dulaglutide | 48 | $42K |
| Rivaroxaban | 150 | $40K |
| Empagliflozin | 104 | $30K |
| Linagliptin | 109 | $29K |
| Mirabegron | 137 | $28K |
| Paliperidone Palmitate | 11 | $27K |
| Atorvastatin Calcium | 777 | $14K |
| Potassium Chloride | 303 | $14K |
| Carbidopa/Levodopa | 33 | $13K |
| Insulin Glargine,hum.Rec.Anlog | 42 | $13K |
| Tiotropium Bromide | 24 | $11K |
| Naloxegol Oxalate | 53 | $9,547 |
Prescribing Profile
Patient Profile
78
Avg Age
58%
Female
2.70
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data